Faulk KE, Anderson-Mellies A, Cockburn M, Green AL. Assessment of enrollment characteristics for Children’s Oncology Group (COG) upfront therapeutic clinical trials 2004-2015. PLoS One. 2020; 15(4)e0230824.
The Safety of SARS-Cov-2 Vaccines in Persons with a Known History of Pegaspargase Allergy: A Single Institution Experience. The Journal of Allergy and Clinical Immunology: In Practice, accepted with revisions.
Clinical Interests
My clinical interest is in early phase clinical trials and translational research in novel pediatric cancer treatments, with a particular emphasis on high risk pediatric cancers and hematologic malignancies.
General Information
Medical Schools:
MD, University of Colorado Denver School of Medicine
(2012)
Graduate Schools:
MSCS, University of Colorado Health Sciences Center
(2019)
Undergraduate Schools:
BA, University of Colorado - Boulder (CO)
(2007)
Internships:
University of Colorado (Children's Hospital Colorado) Program
(2012)
Residency Programs:
University of Colorado (Children's Hospital Colorado) Program, Pediatrics (2015)
Fellowships:
University of Colorado (Children's Hospital Colorado) Program, Pediatric Hematology / Oncology
(2018)
University of Colorado (Children's Hospital Colorado) Program, Experimental Therapeutics
(2019)